Wednesday, July 8, 2026

pharma · Solid Tumors, Colorectal Cancer and Breast Cancer · HER2 Mutant Non-small Cell Lung Cancer · ELVN

Enliven Therapeutics

News and analysis for Enliven Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

Boulder, USA HQ
2019 Founded
75 Employees
Public company Type
ELVN · NYSE Ticker
Company details
Status
Public
HQ
Boulder, USA
Founded
2019
Employees
75
Programs
6
Drugs
13
Patents
5
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Enliven Therapeutics — regulatory, clinical, and market coverage.

News and analysis for Enliven Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Enliven Therapeutics yet.

Back to company overview →